Table 1.
Patient characteristics.
| Controls (N = 37) | Non-FXTAS (N = 90) | FXTAS (N = 23) | P value | |
|---|---|---|---|---|
| Age | 56.53 (7.79) | 52.89 (9.40) | 62.69 (12.27) | <.0001a |
| Education | 14 (3.02) | 15.35 (2.91) | 14.66 (2.45) | .1692a |
| Ethnicity | (N c = 31) | (N = 87) | (N = 22) | |
| Caucasian | 93.5% (29) | 82.8% (72) | 100% (22) | — |
| Hispanic | 6.4% (2) | 12.6% (11) | 0% | — |
| Other | 0% | 4.9% (4) | 0% | — |
| CGG Repeat | 29.61 (5.65) | 86.66 (17.01) | 90.52 (31.38) | .3917b |
| FMR1 mRNA | 1.72 (0.75) | 2.51 (0.94) | 2.24 (0.84) | .2474b |
| AR | 0.54 (0.18) | 0.58 (0.21) | .3712b |
aOverall ANOVA P value.
bComparison between FXTAS and non-FXTAS.
cLess than total sample sizes due to missing ethnicity data.